Mohammed Ali Mohammed Al-Amoodi

Mohammed Al-Amoodi practices at St. Mary's Regional Hospital in Grand Junction, Colorado, part of Intermountain Health.

Mohammed Al-Amoodi's NPI, 1083866149, was assigned on October 21, 2008. Mohammed Al-Amoodi graduated from Jordan University of Science and Technology FOM in 2004. Mohammed Al-Amoodi holds Ohio license 35.136825.

Mohammed Al-Amoodi's primary practice is St. Mary's Regional Hospital, at 2635 N 7th St, Grand Junction, CO 81501 in Mesa County. The practice phone is (970) 298-2260.

Mohammed Al-Amoodi's primary practice is St. Mary's Regional Hospital in Grand Junction, Colorado, part of Intermountain Health. The medical group on file is Grand Junction Palliative Care. Dmand AI also links Mohammed Al-Amoodi to 5 more medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohammed Al-Amoodi practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Mohammed Al-Amoodi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Mohammed Al-Amoodi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Mohammed Al-Amoodi's licenses on file in 9 states: Ohio, Arizona, Colorado, Nevada, Kentucky, Illinois, New York, Tennessee and Missouri.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Mohammed Al-Amoodi treats.

CMS data shows 196 Medicare services from Mohammed Al-Amoodi across 8 procedure codes in 2024, for 147 Medicare patients. Medicare paid $9,900 for them.

CMS counts 147 Medicare patients who saw Mohammed Al-Amoodi in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohammed Al-Amoodi's median patient age at 67, with 46% women.

In 2024, Mohammed Al-Amoodi wrote 1,234 Medicare Part D claims for 245 patients. 74% of them were for generic drugs. CMS names the drug for 1,095 of them, across 19 drugs with 11 or more claims each, at $242,644 in total drug cost. In 2023, CMS named 1,457 claims across 28 drugs.

Dmand AI links 4 papers to Mohammed Al-Amoodi, published from 2012 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement. Mohammed Al-Amoodi has published most often in Curr Probl Cardiol. Mohammed Al-Amoodi's most frequent co-authors are Kamal Shemisa, MD, Abbas Alshami, MD and Chidi Ikenna Amah.

CMS Open Payments shows 170 general payments to Mohammed Al-Amoodi from 33 drug and device companies from 2016 to 2025. Grants make up the largest share, 62% of the total. Medtronic Vascular, Inc. paid the most, $23,122.

Mohammed Al-Amoodi graduated from Jordan University of Science and Technology FOM in 2004.

Mohammed Al-Amoodi is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.